These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37634309)

  • 21. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study.
    Moumneh T; Riou J; Douillet D; Henni S; Mottier D; Tritschler T; Le Gal G; Roy PM
    J Thromb Haemost; 2020 Jun; 18(6):1398-1407. PubMed ID: 32168402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism.
    Ferrazzini E; Méan M; Stalder O; Limacher A; Rodondi N; Aujesky D
    Blood Adv; 2023 Jan; 7(2):205-213. PubMed ID: 35381071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study.
    Choffat D; Farhoumand PD; Jaccard E; de la Harpe R; Kraege V; Benmachiche M; Gerber C; Leuzinger S; Podmore C; Truong MK; Dumans-Louis C; Marti C; Reny JL; Aujesky D; Rakovic D; Limacher A; Rossel JB; Baumgartner C; Méan M
    PLoS One; 2022; 17(5):e0268833. PubMed ID: 35609087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism prophylaxis with anticoagulation in septic patients: a prospective cohort study.
    Zusman O; Paul M; Farbman L; Daitch V; Akayzen Y; Witberg G; Avni T; Gafter-Gvili A; Leibovici L
    QJM; 2015 Mar; 108(3):197-204. PubMed ID: 25190265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients.
    Spyropoulos AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):506-514. PubMed ID: 36485109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
    Chi G; Goldhaber SZ; Kittelson JM; Turpie AGG; Hernandez AF; Hull RD; Gold A; Curnutte JT; Cohen AT; Harrington RA; Gibson CM
    J Thromb Haemost; 2017 Oct; 15(10):1913-1922. PubMed ID: 28762617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria.
    Chamoun N; Ramia E; Lteif C; Salameh P; Zantout H; Ghanem G; Chatila R
    Curr Med Res Opin; 2019 Mar; 35(3):427-433. PubMed ID: 30221541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of falls and bleeding in elderly patients with acute venous thromboembolism.
    Kämpfen P; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Cornuz J; Banyai M; Egloff M; Aschwanden M; Bounameaux H; Rodondi N; Aujesky D
    J Intern Med; 2014 Oct; 276(4):378-86. PubMed ID: 24645727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.
    Schädlich PK; Kentsch M; Weber M; Kämmerer W; Brecht JG; Nadipelli V; Huppertz E
    Pharmacoeconomics; 2006; 24(6):571-91. PubMed ID: 16761905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.
    Kuijer PM; Hutten BA; Prins MH; Büller HR
    Arch Intern Med; 1999 Mar; 159(5):457-60. PubMed ID: 10074953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    J Thromb Haemost; 2020 Mar; 18(3):624-632. PubMed ID: 31785073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
    Goldin M; Lin SK; Kohn N; Qiu M; Cohen SL; Barish MA; Gianos E; Diaz A; Richardson S; Giannis D; Chatterjee S; Coppa K; Hirsch JS; Ngu S; Firoozan S; McGinn T; Spyropoulos AC
    J Thromb Thrombolysis; 2021 Nov; 52(4):1032-1035. PubMed ID: 34146235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).
    Chamoun N; Matta S; Aderian SS; Salibi R; Salameh P; Tayeh G; Haddad E; Ghanem H
    Sci Rep; 2019 Dec; 9(1):18366. PubMed ID: 31797897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of very early major bleeding risk in acute pulmonary embolism: an independent external validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score.
    Villiger R; Méan M; Stalder O; Limacher A; Rodondi N; Righini M; Aujesky D
    J Thromb Haemost; 2023 Oct; 21(10):2884-2893. PubMed ID: 37149148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
    Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.